» Articles » PMID: 20842367

Neuropathology of the Recessive A673V APP Mutation: Alzheimer Disease with Distinctive Features

Abstract

Mutations of three different genes, encoding β-amyloid precursor protein (APP), presenilin 1 and presenilin 2 are associated with familial Alzheimer's disease (AD). Recently, the APP mutation A673V has been identified that stands out from all the genetic defects previously reported in these three genes, since it causes the disease only in the homozygous state (Di Fede et al. in Science 323:1473-1477, 2009). We here provide the detailed neuropathological picture of the proband of this family, who was homozygous for the APP A673V mutation and recently came to death. The brain has been studied by histological and immunohistochemical techniques, at the optical and ultrastructural levels. Cerebral Aβ accumulation and tau pathology were severe and extensive. Peculiar features were the configuration of the Aβ deposits that were of large size, mostly perivascular and exhibited a close correspondence between the pattern elicited by amyloid stainings and the labeling obtained with immunoreagents specific for Aβ40 or Aβ42. Moreover, Aβ deposition spared the neostriatum while deeply affecting the cerebellum, and therefore was not in compliance with the hierarchical topographical sequence of involvement documented in sporadic AD. Therefore, the neuropathological picture of familial AD caused by the APP recessive mutation A673V presents distinctive characteristics compared to sporadic AD or familial AD inherited as a dominant trait. Main peculiar features are the morphology, structural properties and composition of the Aβ deposits as well as their topographic distribution in the brain.

Citing Articles

Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues.

Jiang P, Dickson D Acta Neuropathol Commun. 2025; 13(1):53.

PMID: 40057802 PMC: 11889819. DOI: 10.1186/s40478-025-01969-2.


Reduced GLP-1R availability in the caudate nucleus with Alzheimer's disease.

Barrett E, Ivey G, Cunningham A, Coffman G, Pemberton T, Lee C Front Aging Neurosci. 2024; 16:1350239.

PMID: 38915346 PMC: 11194438. DOI: 10.3389/fnagi.2024.1350239.


Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.

Ciurea A, Mohan A, Covache-Busuioc R, Costin H, Glavan L, Corlatescu A Int J Mol Sci. 2023; 24(13).

PMID: 37445986 PMC: 10341997. DOI: 10.3390/ijms241310809.


Alleviating the unwanted effects of oxidative stress on Aβ clearance: a review of related concepts and strategies for the development of computational modelling.

Somin S, Kulasiri D, Samarasinghe S Transl Neurodegener. 2023; 12(1):11.

PMID: 36907887 PMC: 10009979. DOI: 10.1186/s40035-023-00344-2.


TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer's disease.

White H, Webb R, McKnight I, Legg K, Lee C, Lee P Front Genet. 2022; 13:936151.

PMID: 36406122 PMC: 9670164. DOI: 10.3389/fgene.2022.936151.